fluticasone propionate
Showing 1 - 25 of 775
Bioequivalence Trial in Larissa (Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals,
Recruiting
- Bioequivalence
- Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
- ADVAIR DISKUS® 500/50
-
Larissa, Thessaly, GreeceBECRO Clinical Facility
Aug 29, 2023
Bioequivalence Trial in Larissa (Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals,
Recruiting
- Bioequivalence
- Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
- ADVAIR DISKUS® 250/50
-
Larissa, Thessaly, GreeceBECRO Clinical Facility
Aug 1, 2023
Bioequivalence Trial (Fluticasone propionate 1000 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals, ADVAIR DISKUS
Not yet recruiting
- Bioequivalence
- Fluticasone propionate 1000 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
- ADVAIR DISKUS 100/50
- (no location specified)
Jan 20, 2023
Asthma Trial in Athens (Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals, ADVAIR
Not yet recruiting
- Asthma
- Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals
- +2 more
-
Athens, GreeceBECRO Ltd.
Jan 20, 2023
Sleep Apnea, Chronic Nasal Congestion Trial in Tampa (Oxymetazoline Hydrochloride, Placebo)
Recruiting
- Sleep Apnea
- Chronic Nasal Congestion
- Oxymetazoline Hydrochloride
- Placebo
-
Tampa, FloridaUsf Asthma Allergy and Immunology Cru
Nov 14, 2022
Bronchial Asthma Trial in India (Fluticasone propionate Inhalation Aerosol 44 mcg, FLOVENT HFA 44 mcg, Matching Placebo inhaler)
Recruiting
- Bronchial Asthma
- Fluticasone propionate Inhalation Aerosol 44 mcg
- +2 more
-
Ahmedabad, Gujarat, India
- +10 more
May 24, 2022
Seasonal Allergic Rhinitis Trial in Mississauga (Azelastine HCl + fluticasone propionate nasal spray, Placebos, fluticasone
Completed
- Seasonal Allergic Rhinitis
- Azelastine hydrochloride + fluticasone propionate nasal spray
- +2 more
-
Mississauga, Ontario, CanadaInflamax Research
Feb 4, 2022
Asthma, Bioequivalence Trial in Larissa (Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent
Active, not recruiting
- Asthma
- Bioequivalence
- Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals
- FLOVENT DISKUS
-
Larissa, Thessaly, GreeceBECRO Clinical Facility
May 25, 2022
Compare Bioequivalence of Two Fluticasone Propionate 0.05%
Completed
- Healthy
- Fluticasone Propionate 0.05% Cream-Reference Product
- Fluticasone Propionate 0.05% Cream-Test product
- (no location specified)
Oct 8, 2021
Compare Bioavailability of Two Fluticasone Propionate 0.005%
Completed
- Healthy
- Fluticasone Propionate 0.005% Ointment-Reference Product
- Fluticasone Propionate 0.005% Ointment-Test product
- (no location specified)
Oct 7, 2021
Allergic Rhinitis Trial in Taichung, Tainan, Taipei (azelastine/fluticasone 137/50 mcg nasal spray, Dymista™)
Completed
- Allergic Rhinitis
- azelastine/fluticasone 137/50 mcg nasal spray
- Dymista™
-
Taichung, Taiwan
- +4 more
Sep 20, 2023
Asthma Trial in Raleigh, Edmond, San Antonio (Treatment A: Fp MDPI, Treatment B: FS MDPI, Treatment C Flovent)
Completed
- Asthma
- Treatment A: Fp MDPI
- +3 more
-
Raleigh, North Carolina
- +2 more
Nov 6, 2021
Asthma Trial (mometasone furoate dry powder inhaler, fluticasone propionate hydrofluoroalkane (HFA), montelukast)
Completed
- Asthma
- mometasone furoate dry powder inhaler
- +2 more
- (no location specified)
Feb 7, 2022
Perennial Allergic Rhinitis Trial (Placebo for MF, Placebo for FP, Mometasone)
Completed
- Perennial Allergic Rhinitis
- Placebo for MF
- +3 more
- (no location specified)
Feb 7, 2022
Asthma Trial in Huntington Beach, Raleigh, San Antonio (Fluticasone Propionate MDPI, Fluticasone Propionate/Salmeterol MDPI,
Completed
- Asthma
- Fluticasone Propionate MDPI
- +2 more
-
Huntington Beach, California
- +2 more
Nov 5, 2021
Eosinophilic Esophagitis Trial in Indianapolis, Boston, Melbourne (APT-1011, Placebo oral tablet)
Completed
- Eosinophilic Esophagitis
- APT-1011
- Placebo oral tablet
-
Indianapolis, Indiana
- +2 more
Nov 13, 2022
Eustachian Tube Dysfunction Trial in Los Angeles (Fluticasone Propionate 93 MCG/1 ACTUATION Nasal Spray, Placebo Nasal Spray)
Recruiting
- Eustachian Tube Dysfunction
- Fluticasone Propionate 93 MCG/1 ACTUATION Nasal Spray
- Placebo Nasal Spray
-
Los Angeles, California
- +2 more
Dec 15, 2022
Asthma Trial in Miami Lakes (Fluticasone Propionate and Salmeterol Inhalation Powder, Placebo Inhalation Powder)
Completed
- Asthma
- Fluticasone Propionate and Salmeterol Inhalation Powder
- Placebo Inhalation Powder
-
Miami Lakes, FloridaStudy Site 101
Aug 31, 2021
Seasonal Allergic Rhinitis Trial in Mississauga (Treatment A (Dymista): Fixed drug combination of azelastine HCl and fluticasone
Completed
- Seasonal Allergic Rhinitis
- Treatment A (Dymista): Fixed drug combination of azelastine hydrochloride and fluticasone propionate nasal spray at Visit 3
- +3 more
-
Mississauga, Ontario, CanadaCliantha Research
Feb 11, 2022
Asthma Trial in Spartanburg (Fluticasone propionate pressurized metered dose inhaler, Flovent HFA pressurized metered dose
Completed
- Asthma
- Fluticasone propionate pressurized metered dose inhaler
- +2 more
-
Spartanburg, South CarolinaSite 1
Aug 31, 2021
Asthma Trial (Mometasone furoate/formoterol (MF/F) MDI, Fluticasone propionate/salmeterol (F/SC) DPI)
Completed
- Asthma
- Mometasone furoate/formoterol (MF/F) MDI
- Fluticasone propionate/salmeterol (F/SC) DPI
- (no location specified)
Feb 7, 2022
Eosinophilic Esophagitis Trial in Cleveland (Fluticasone Propionate, Budesonide)
Recruiting
- Eosinophilic Esophagitis
- Fluticasone Propionate
- Budesonide
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center
Jul 1, 2022